Skip to search boxSkip to navigationSkip to main content

Trichosporon infection

  • Henry Ford Health System
Scholary Output:
Contribution to journal
Review article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Yeast exist throughout nature in association with soil, plants, mammals, and fish. As a result of this continued exposure, all humans are exposed to many different types of yeast through a variety of different routes. Recently, because of the increased population of immunocompromised patients and the extensive use of different antifungals, the incidence of infections due to non-Candida yeast has increased. Of these classic "nonpathogenic" yeast, Trichosporon species have been increasingly described producing deep-seated and disseminated infections that are difficult to predict and diagnose. In addition, the different species of Trichosporon have been found to be less susceptible or resistant to commonly used antifungals. Because of this intrinsic variation in antifungal susceptibility and the fact that these infections are generally seen in severely immunocompromised hosts, they are associated with significant morbidity and mortality, despite their known "nonpathogenic" characteristics described in superficial infections.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 52-58 (7 pages)

Journal (Volume, Issue Number)

Current Fungal Infection Reports (Volume 4, Issue 1)

Publication milestones

  • Published - 03/2010

Publication status

Published - 03/2010

ISSN

1936-3761

Publication IDs

  • Scopus: 79952193879

Publication metrics

Metrics

SciVal
FWCI
0.20
SciVal
Author count
1
SciVal
citations
10
SciVal
Paper percentile
63
Scopus
citations
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
14
Citation count
9

Funding Details

Disclosure Dr. Vazquez has received grants from and been a speaker for Pfizer; has been a speaker and consultant for Astellas; and has received grants from Merck.
FunderFunding numbers
Merck
-